Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine - 22/05/16
Abstract |
Biomarkers have become an integral part of practicing medicine, especially in heart failure. The natriuretic peptides are commonly used in the evaluation of heart failure, but their role extends beyond diagnosis and includes risk stratification and management of heart failure patients. Newer biomarkers have arrived and are becoming part of routine care of heart failure patients. Both ST2 and high-sensitivity troponin have significant prognostic value for mortality, but also may assist in the titration of medical therapy. Procalcitonin can help guide appropriate antibiotic use in patients with heart failure. The ability to appropriately use and interpret these biomarkers is imperative to the care of heart failure patients, especially as these newer biomarkers become widely used.
Le texte complet de cet article est disponible en PDF.Keywords : Biomarkers, BNP, Heart failure, Procalcitonin, ST2, Troponin
Plan
| Funding: None. |
|
| Conflict of Interest: ASM: Consultant: Sphingotech, Critical Dx; Stocks: None; Speaking: Alere, Abbott, Critical Dx; NW: none. |
|
| Authorship: Both authors participated in the writing of this manuscript, had the opportunity to review and edit the manuscript, and agreed with submission of the manuscript. |
Vol 129 - N° 6
P. 560-567 - juin 2016 Retour au numéro
Article précédent
- A Novel Diagnostic Approach for Evaluating Suspected Coronary Artery Disease
- William E. Boden
- Top 10 Things Primary Care Physicians Should Know About Maintenance Immunosuppression for Transplant Recipients
- Yeong-Hau H. Lien
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?